相关实验视频

Updated: Jan 10, 2026

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

在质瘤中重新编程免疫抑制瘤微环境提高了免疫介导基因疗法的有效性

Brandon L McClellan, Jorge A Peña Agudelo, Anzar A Mujeeb

bioRxiv : the preprint server for biology

|November 26, 2025

概括

突变的IDH1 (mIDH1) 质瘤显示CD73的表达较低,减少了腺. CD73阻断与基因疗法相结合,通过增强抗瘤T细胞活性,显著改善了野生型IDH1 (wtIDH1) 质瘤的存活率.

科学领域:

神经瘤学神经瘤学
癌症免疫学癌症免疫学
分子生物学分子生物学

背景情况:

质瘤是原发性恶性脑瘤,其中许多存在异酸脱酶1 (IDH1) 的突变.
突变IDH1 (mIDH1) 促进了免疫宽容的瘤微环境 (TME),但CD73产生的腺素有助于免疫抑制.
野生型IDH1 (wtIDH1) 质瘤表现出高CD73表达,呈现出潜在的治疗点.

研究的目的:

研究mIDH1对CD73表达和质瘤中的腺素水平的影响.
评估CD73阻断作为单一疗法和与基因疗法结合用于质瘤治疗.

主要方法:

在mIDH1和wtIDH1质瘤细胞中分析CD73表达.
评估与CD73表达相关的腺水平.
在活体研究中,使用带质瘤的小鼠测试单独的CD73抑制和与Ad-TK和Ad-Flt3L基因疗法相结合.

主要成果:

由于DNA高甲基化,mIDH1质瘤细胞表现出CD73表达的减少,导致腺水平降低.
作为单一治疗的CD73抑制并没有改善wtIDH1质瘤携带小鼠的存活率.
组合疗法 (用Ad-TK/Ad-Flt3L阻断CD73) 显著增强治疗效果,并增加了在wtIDH1质瘤中抗质瘤T细胞的活性.

结论:

CD73在质瘤中调节腺水平方面发挥作用,受IDH1突变状态的影响.
仅仅抑制CD73是治疗wtIDH1质瘤的不足.
涉及CD73阻断和免疫刺激基因疗法的组合疗法为wtIDH1质瘤提供了一种有希望的,临床可转换的方法.

更多相关视频

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Published on: November 28, 2015

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...